Phase 1 trail of KT‐413, a degrader of IRAK4 and IMID substrates, in adult patients with relapsed or refractory B‐cell non‐Hodgkins's lymphomas Meeting Abstract
| Authors: | Lue, J. K.; Stevens, D. A.; Ayers, E.; Dunleavy, K.; Mattour, A.; Mishkin, A.; McDonald, A.; Agarwal, S.; Henrick, P.; Perea, R.; Gollerkeri, A.; Gollob, J.; Westin, J. |
| Abstract Title: | Phase 1 trail of KT‐413, a degrader of IRAK4 and IMID substrates, in adult patients with relapsed or refractory B‐cell non‐Hodgkins's lymphomas |
| Meeting Title: | 17th International Conference on Malignant Lymphoma (ICML) |
| Journal Title: | Hematological Oncology |
| Volume: | 41 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Jun 13-17 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2023-06-01 |
| Start Page: | 808 |
| End Page: | 809 |
| Language: | English |
| DOI: | 10.1002/hon.3165_657 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 657 -- Source: Cinahl |
